The BalancedInvestor Club

GRML Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)—0.0% YoY
Profit margin0.0%BASIC MATERIALS
Market cap$36.6MMicro cap

Valuation

Forward P/E
—
PEG ratio
—
P/B
—
P/S (TTM)
—
EV/EBITDA
—

Profitability & growth

ROE (TTM)
-85.6%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
—
Beta
2.46
Last earnings
May 20, 2026 · Reported $-0.15
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Greenland Mines Ltd

Greenland Mines Ltd develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is headquartered in Omaha, Nebraska.

Classification

Sector
Basic Materials
Industry
Other Precious Metals & Mining
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
1300 SOUTH BOULEVARD, CHARLOTTE, NC
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$36.6M
Shares outstanding$121.2M
52W high$0.74
52W low$0.21

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer